AlphaCrest Capital Management’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-55,184
Closed -$1.33M 1331
2022
Q2
$1.33M Buy
55,184
+2,488
+5% +$66.8K 0.06% 528
2022
Q1
$1.63M Buy
52,696
+47,004
+826% +$1.69M 0.09% 325
2021
Q4
$258K Sell
5,692
-42,853
-88% -$1.83M 0.01% 1293
2021
Q3
$2.11M Buy
48,545
+43,298
+825% +$1.88M 0.11% 283
2021
Q2
$242K Buy
+5,247
New +$242K 0.01% 1165
2021
Q1
Sell
-22,272
Closed -$883K 1261
2020
Q4
$883K Buy
22,272
+4,956
+29% +$184K 0.07% 360
2020
Q3
$677K Buy
+17,316
New +$663K 0.07% 427
2020
Q1
Sell
-24,676
Closed -$805K 1190
2019
Q4
$805K Sell
24,676
-5,724
-19% -$188K 0.07% 476
2019
Q3
$1.03M Buy
+30,400
New +$1.05M 0.06% 554

Other funds holding NEOG

AlphaCrest Capital Management's NEOG Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of Neogen (NEOG) in Q3 2022, closing a stake of 55,184 shares — an estimated $1.33M sold.

AlphaCrest Capital Management first reported a position in NEOG in Q3 2019 and held it in 9 quarters. The position peaked at $2.11M in Q3 2021. 385 funds tracked by Wall St. Rank hold NEOG as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining Neogen position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 55,184 Neogen shares in Q3 2022, an estimated $1.33M.
  • AlphaCrest Capital Management first reported a position in Neogen in Q3 2019 and held it in 9 quarters.
  • AlphaCrest Capital Management's Neogen position peaked at $2.11M in Q3 2021.
  • 385 funds tracked by Wall St. Rank held Neogen as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.